• 1
    Vicenti F, Arnaud SB, Recker R, Genant H, Amend WJC Jr, Feduska NJ, Salvatierra O Jr 1994 Parathyroid and bone response of the diabetic patient to uremia. Kidney Int 25:677682.
  • 2
    Hernandez D, Concepcion MT, Lorenzo V, Martinez ME, Rodriguez A, De Bonis E, Gonzalez-Posada JM, Felsenfeld AJ, Rodriguez M, Torres A 1994 Adynamic bone disease with negative aluminium staining in predialysis patients: Prevalence and evolution after maintenance dialysis. Nephrol Dial Transplant 9:517523.
  • 3
    Pei Y, Hercz G, Greenwood C, Segre G, Manuel A, Saiphoo C, Fenton S, Sherrard D 1993 Renal osteodystrophy in diabetic patients. Kidney Int 44:159164.
  • 4
    Quarles LD, Lobaugh B, Murphy G 1992 Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia. J Clin Endocrinol Metab 75:145150.
  • 5
    Torres A, Lorenzo V, Hernandez D, Rodriguez JC, Concepcion MT, Rodriguez AP, Hernandez A, de Bonis E, Darias E, Gonzalez-Posada JM, Losada M, Rufino M, Felsenfeld AJ, Rodriguez M 1995 Bone disease in predialysis, hemodialysis, and CAPD patients: Evidence of a better bone response to PTH. Kidney Int 47:14341442.
  • 6
    Argiles A, Kerr PG, Canaud B, Flavier JL, Mion C 1993 Calcium kinetics and the long-term effects of lowering dialysate calcium concentration. Kidney Int 43:630640.
  • 7
    Fernandez E, Borras M, Pais B, Montoliu J 1995 Low-calcium dialysate stimulates parathormone secretion and its long-term use worsens secondary hyperparathyroidism. J Am Soc Nephrol 6:132135.
  • 8
    Felsenfeld AJ, Rodriguez M, Dunlay R, Llach F 1991 A comparison of parathyroid-gland function in haemodialysis patients with different forms of renal osteodystrophy. Nephrol Dial Transplant 6:244251.
  • 9
    Rodriguez M, Felsenfeld AJ, Williams C, Pederson JA, Llach F 1991 The effect of long-term intravenous calcitriol administration on parathyroid function in hemodialysis patients. J Am Soc Nephrol 2:10141020.
  • 10
    Pahl M, Jara A, Bover J, Rodriguez M, Felsenfeld AJ 1996 The set point of calcium and the reduction of parathyroid hormone in hemodialysis patients. Kidney Int 49:226231.
  • 11
    Rodriguez M, Caravaca F, Fernandez E, Borrego MJ, Lorenzo V, Cubero J, Martin-Malo A, Betriu A, Rodriguez AP, Felsenfeld AJ 1997 Evidence for both abnormal set point of calcium and adaptation to serum calcium in hemodialysis patients with hyperparathyroidism. J Bone Miner Res 12:347355.
  • 12
    Brent GA, LeBoff MS, Seely EW, Conlin PR, Brown EM 1988 Relationship between the concentration and rate of change of calcium and serum intact parathyroid hormone levels in normal humans. J Clin Endocrinol Metab 67:944950.
  • 13
    Ramirez JA, Goodman WG, Belin TR, Gales B, Segre GV, Salusky IB 1994 Calcitriol therapy and calcium-regulated PTH secretion in patients with secondary hyperparathyroidism. Am J Physiol 267:E961E967.
  • 14
    Goodman WG, Belin T, Gales B, Juppner H, Segre GV, Salusky IB 1995 Calcium-regulated parathyroid hormone release in patients with mild or advanced secondary hyperparathyroidism. Kidney Int 48:15531558.
  • 15
    Felsenfeld AJ, Rodriguez M, Coleman M, Ross D, Llach F 1989 Desferrioxamine therapy in hemodialysis patients with aluminum-associated bone disease. Kidney Int 35:13711378.
  • 16
    Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR 1987 Bone histomorphometry: Standardization of nomenclature, symbols, and units. J Bone Miner Res 2:595610.
  • 17
    Felsenfeld AJ, Rodriguez M 1996 The set point of calcium—another view. Nephrol Dial Transplant 11:17221725.
  • 18
    Bland JM, Altman DG 1986 Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:307310.
  • 19
    Hercz G, Pei Y, Greenwood C, Manuel A, Saiphoo C, Goodman WG, Segre GV, Fenton S, Sherrard DJ 1993 Aplastic osteodystrophy without aluminum: The role of “suppressed” parathyroid function. Kidney Int 44:860866.
  • 20
    Montenegro J, Saracho R, Gonzalez O, Moina I, Martinez I 1997 Reversibility of parathyroid gland suppression in CAPD patients with low i-PTH levels. Clin Nephrol 48:359363.
  • 21
    Combe C, Morel D, de Precigout V, Blanchetier V, Bouchet JL, Potaux L, Fournier A, Aparacio M 1995 Long-term control of hyperparathyroidism in advanced renal failure by low-phosphorus low-protein diet supplemented with calcium (without changes in plasma calcitriol). Nephron 70:287295.
  • 22
    Rodriguez M, Caravaca F, Fernandez E, Borrego MJ, Lorenzo V, Cubero J, Martin-Malo A, Betriu A, Jimenez A, Torres A, Felsenfeld AJ 1999 Parathyroid function as a determinant of the response to calcitriol treatment in the hemodialysis patient. Kidney Int 56:306317.
  • 23
    Hercz G, Sherrard DJ, Chan W, Pei Y 1994 Aplastic osteodystrophy: Follow-up after 5 years. J Am Soc Nephrol 5:851 (abstract).
  • 24
    Fournier A, Moriniere P, Marie A 1995 Adynamic bone disease - is it actually a disease? Nephrol Dial Transplant 10:454457.
  • 25
    Kurz P, Monier-Faugere MC, Bognar B, Werner E, Roth P, Vlachojannis J, Malluche HH 1994 Evidence for abnormal calcium homeostasis in patients with adynamic bone disease. Kidney Int 46:855861.
  • 26
    Hsu CH 1997 Are we mismanaging calcium and phosphate metabolism in renal failure? Am J Kidney Dis 29:641649.
  • 27
    Fine A, Fleming S, Leslie W 1995 Calciphylaxis presenting with calf pain and plaques in four continuous ambulatory peritoneal dialysis patients and in one predialysis patient. Am J Kidney Dis 25:498502.
  • 28
    Ruggian JC, Maesaka JK, Fishbane S 1996 Proximal calciphylaxis in four insulin-requiring diabetic hemodialysis patients. Am J Kidney Dis 28:409414.
  • 29
    Bleyer AJ, Choi M, Igwemezie B, de la Torre E, White WL 1998 A case control study of proximal calciphylaxis. Am J Kidney Dis 32:376383.
  • 30
    Coates T, Kirkland GS, Dymock RB, Murphy BF, Brealey JK, Mathew TH, Disney APS 1998 Cutaneous necrosis from calcific uremic arteriolopathy. Am J Kidney Dis 32:384391.
  • 31
    Mawad HW, Sawaya BP, Sarin R, Malluche HH 1999 Calcific uremic arteriolopathy in association with low turnover uremic bone disease. Clin Nephrol 52:160166.
  • 32
    Moyses, RMA, Pereira RC, Machado dos Reis L, Sabbaga E, Jorgetti V 1999 Dynamic tests of parathyroid hormone secretion using hemodialysis and calcium infusion cannot be compared. Kidney Int 56:659665.
  • 33
    Hruska KA, Teitelbaum SL, Kopelman R, Richardson CA, Miller P, Debman J, Martin K, Slatopolsky E 1978 The predictability of the histological features of uremic bone disease by non-invasive techniques. Metab Bone Dis Rel Res 1:3944.